<< Opexa Therapeutics releases Phase IIb TERMS clinical study results | Proteostasis Therapeutics to use GeneGo's MetaCore integrated software >>

Read in | English | Español | 日本語 | Norsk

NanoViricides' drug pipeline to be discussed at NanoBusiness2009

Published on September 8, 2009 at 7:46 AM · No Comments

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been asked to present a talk at NanoBusiness2009 - the 8th annual NanoBusiness Conference.

Dr. Diwan will speak about the nanoviricides™ drug pipeline, including Influenza (FluCide™), HIV (HIVCide™), antiviral eye-drops (EKCCide™) and the newly initiated Herpes “cold sores” and genital herpes preclinical stage program. He will speak about how the nanoviricides technology platform has enabled rapid drug development against a number of diseases caused by many different viruses. Dr. Diwan will speak in the session entitled “New Pharmaceutical Compounds Based on Soft Nanotechnology: Novel Classes of Therapeutics” on Wednesday, September 9. The Conference is being held at the McCormick Place, Chicago, IL.

http://www.nanoviricides.com/

7e39b5b5-d79c-4bdf-aebb-564303501319|0|.0

Posted in: Medical Science News | Pharmaceutical News

Tags: Bird Flu, Cold Sores, Genital Herpes, H1N1, H5N1, Hepatitis C, Herpes, Influenza, Nanotechnology, Swine Flu, Virus

Related posts

Sinovac third quarter sales increase 60.8% to $15.4 millionSinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its...
Medivir, Meda renegotiate agreement for cold sores medicine, XereseMedivir AB, the emerging research-based specialty pharmaceutical company focused on infectious disea...
Biogen, Elan announce clinical utility data of two-step ELISA to detect anti-JCV antibodiesBiogen Idec and Elan Corporation, plc today announced data further supporting the potential clinical...
Green Cross receives KFDA approval to manufacture, market i.v. peramivir: BioCryst PharmaceuticalsBioCryst Pharmaceuticals, Inc. today announced that its partner, Green Cross Corporation has receive...
FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDARoxane Laboratories, Inc. announced today the Abbreviated New Drug Application (ANDA) approval of Va...
NanoViricides anti-HIV drug candidates demonstrate efficacy in cell culture studies with HIV-1 isolatesNanoViricides, Inc. reports that its anti-HIV drug candidates demonstrated efficacy in the recently ...
Recent releases in Global HealthA Scientific American article examines recent efforts to tackle neglected tropical diseases (NTDs). ...
Mintel predicts increased sales of OTC drugs in upcoming monthsAutumn has arrived in the northern hemisphere and with shades of yellow and orange comes a less-welc...
Liquidia founder Dr. Joseph DeSimone honoured with the NIH Director’s Pioneer AwardLiquidia Technologies today announced its founder, Dr. Joseph DeSimone, has received the National In...
WHO has a go at China over new birdflu strainThe World Health Organisation (WHO) says the new strain of the H5N1 bird flu virus currently circula...
Canadian health groups urge ban on exportation of pharmaceutical drugs from Canada to the U.S.Canadian health groups today called on the Government of Canada to ban the exportation of pharmaceut...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.